EFTA01493047.pdf

FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 5/1/12 to 5/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized Gainr Loss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 16.57 16,535.000 273,984.95 251,475.52 22,509.43 04033A-10-0 ARIA BI0GEN IDEC INC 130.75 2.095 000 273,921.25 250,454.95 23,466.30 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 62.91 1.003.000 000 629,100.00 1,000,000.00 (370,900.00) 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-0715111 MS 21 09 2515A1-A7-6 FACEBOOK INCA 29.80 35,000.000 1,038,000.00 1,330,000.00 (294,000.00) 30303M-10.2 FB HSBC MARKET PLUS SPX 05117/13 95.49 5,000,000.000 4,774,500.00 5,000,000.00 (225,500.00) 72% KO BARRIER- 0%CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-X0-1 JP Morgan Account W23560001 Page 5 of 25 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-000 15874 Chase CONFIDENTIAL SDNY_GM_00285072 EFTA01493047